InvestorsHub Logo
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

Re: Work Harder post# 24911

Friday, 05/14/2021 11:02:55 AM

Friday, May 14, 2021 11:02:55 AM

Post# of 27659
Imugene (ASX:IMU) reports clinical milestone for HER-Vaxx ...
themarketherald.com.au › imugene-asximu-reports
Apr 21, 2021 · Imugene (IMU) has achieved a clinical milestone for progression-free survival (PFS) in its phase two gastric cancer clinical trial. The study is assessing whether the company's HER-Vaxx immunotherapy can improve, firstly, overall survival and, secondly, progression-free survival.
https://themarketherald.com.au/imugene-asximu-reports-clinical-milestone-for-her-vaxx-2021-04-21/

Nice when there using VIROSOMES
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News